Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcis”

208 trials

Showing 20 of 208 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351
What this trial is testing

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05484375
What this trial is testing

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06509009
What this trial is testing

Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma by AJCC V8 Stage
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00536614
What this trial is testing

Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 86
Early research (Phase 1)Study completedNCT00454649
What this trial is testing

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Who this might be right for
Neoplasms
Pfizer 102
Testing effectiveness (Phase 2)Study completedNCT03778593
What this trial is testing

FOLFIRINOX for 2nd-line Treatment of BTC

Who this might be right for
Biliary Tract Cancer
Dong-A University Hospital 34
Not applicableEnded earlyNCT02512692
What this trial is testing

Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Medical University of South Carolina 6
Testing effectiveness (Phase 2)Study completedNCT02365766
What this trial is testing

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

Who this might be right for
Urothelial CarcinomaBladder Cancer
Jason R. Brown 83
Large-scale testing (Phase 3)Active Not RecruitingNCT03732677
What this trial is testing

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 1,063
Testing effectiveness (Phase 2)Ended earlyNCT00859339
What this trial is testing

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Noah Hahn, M.D. 9
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Not applicableStudy completedNCT04871321
What this trial is testing

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
CHA University 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT02632305
What this trial is testing

See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer

Who this might be right for
Unresectable Biliary Tract Cancer
AHS Cancer Control Alberta 45
Testing effectiveness (Phase 2)UnknownNCT05672537
What this trial is testing

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Who this might be right for
DurvalumabIntrahepatic CholangiocarcinomaGemcis
Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01320254
What this trial is testing

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

Who this might be right for
Cholangiocarcinomas
Hannover Medical School 93
Large-scale testing (Phase 3)Looking for participantsNCT06467357
What this trial is testing

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
AstraZeneca 620
Testing effectiveness (Phase 2)Looking for participantsNCT05305131
What this trial is testing

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 50
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Ended earlyNCT00924209
What this trial is testing

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
NSCLCStage IIIA (N2)
National Cancer Institute (NCI) 7
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation